Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aussie Scientists To Test Device To Deliver Tailor-Made Cancer Drugs

This article was originally published in PharmAsia News

Executive Summary

Australian researchers expect to begin clinical trials soon to test a new device for delivering chemotherapy to cancer patients. The device is the EnGenlC Delivery Vehicle developed by a pair of Sydney doctors to enable nano cells to enter cancer cells. The EDV is designed to deliver drugs directly to solid tumors such as those involved in colon, head, liver, lung and rectal cancers. One of the developing physicians said successful trials could lead the way in changing treatment from "one size fits all" to tailor-made medicine. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts